跳至主要内容
临床试验/IRCT2014110919870N1
IRCT2014110919870N1已完成2 期

Efficacy and safety of platelet-rich plasma (PRP) in the treatment of male pattern hair loss (androgenetic alopecia): a pilot, phase 2 clinical trial

Mehrashkar company0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 60 years(—)
性别
Male

入选标准

  • Androgenetic alopecia based on a clinical diagnosis made by a dermatologist;male subjects; 18-50 years old; hair loss longer than 6 months; Hamilton-Norwood grade III-VI;Willingness to participate in the study and giving written informed consent.
  • Exclusion criteria:
  • Any topical or systemic treatment for hair loss in the past 6 months;Scalp infection
  • Malignant disease;Receiving chemotherapy or any immunosuppressive medication
  • Auto-immune disease (Hashimoto, rheumatoid arthritis, lupus, ….);Use of any growth factor containing medication;Hemoglobin level below 10, thrombocytopenia (or platelet count below 100,000);Serum albumin below 2.5 g/dl;History of vascular surgery in the past three months;Addiction to oral or intravenous narcotics;
  • Any systemic disease interacting with hair growth ;History of hematologic disorders;
  • Patient currently enrolled or previously enrolled (within last 3 months) in another clinical trial

排除标准

  • 未提供

研究者

发起方
Mehrashkar company

相似试验

Efficacy and safety of platelet-rich plasma (PRP) in... | 临床试验